Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?

To: Jesse Schulman who wrote (346)	9/8/1999 1:06:00 PM
From: rkrw	Read Replies (1) \| Respond to of 804

<My concern, if you'll forgive my spelling it out, is that the first new thalidomide birth in the US is going to cause such a media storm that it'll be yanked. Or am I being paranoid?> Plenty of drugs are teratogenic, including a commonly used acne medication. The risk was in gaining approval despite the drugs checkered history and political pressure from thalidomide survivor activist groups. With approval and the strict guidelines I mentioned in my prior post, the FDA made the decision that the benefits outweigh the risks. The FDA pulling the plug is not a risk I am concerned about.